Zai Lab is a Shanghai-based biopharmaceutical company that sells prescription medicines for cancer, autoimmune and infectious diseases. It last closed at $23.53 on Nov 17, up 0.26% on the day. In the past 30 days there were 3 dark pool prints totaling $7.3M, the largest $3.7M.
ZLAB · as of the Nov 17 close · updated after every close
Moving sideways
The stock is 1% below its 20 day and 4% below its 50 day average. It is 9% above its 200 day average, so the longer trend is still up. Momentum is neutral (RSI 46). The nearest support is the Pivot at $23.52, and the nearest resistance the 20 day average at $23.88.
Short trendNeutral
Long trendBullish
MomentumNeutral
StretchNormal
VolatilityHigh, 6.3%/day
Key levels
$29.0252 week high+23.3%
$25.50Swing high (Oct 21)+8.4%
$24.5250 day average+4.2%
$23.99Pivot R1+2.0%
$23.8820 day average+1.5%
$23.53Last close
$23.52Pivot−0.0%
$23.36100 day average−0.7%
$23.06Pivot S1−2.0%
$22.12Swing low (Oct 14)−6.0%
$21.37200 day average−9.2%
$15.9652 week low−32.2%
Indicators
RSI (14)
46.30
Middle of its range
Neutral
MACD
0.13
Above its signal line
Bullish
Stochastic
32.2
Middle of its range
Neutral
ADX (14)
13.5
No clear trend
Williams %R
-72.2
Oversold below −80, overbought above −20
Neutral
CCI (20)
-17.2
Oversold below −100, overbought above 100
Neutral
Rate of change
+7.2%
Change over 10 sessions
Bullish
ATR (14)
$1.48
Typical daily range, 6.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Above
Rising
Short trendBullish
Long trendNot enough history
MomentumFading
StretchNormal
VolatilityNormal, 12.5%/day
Key levels
$29.0252 week high+23.3%
$25.50Swing high (Oct 21)+8.4%
$24.5250 day average+4.2%
$23.99Pivot R1+2.0%
$23.8820 day average+1.5%
$23.53Last close
$23.52Pivot−0.0%
$23.36100 day average−0.7%
$23.06Pivot S1−2.0%
$22.12Swing low (Oct 14)−6.0%
$21.37200 day average−9.2%
$15.9652 week low−32.2%
Indicators
RSI (14)
51.32
Middle of its range
Neutral
MACD
0.82
Below its signal line
Bearish
Stochastic
49.4
Middle of its range
Neutral
ADX (14)
19.7
No clear trend
Williams %R
-72.2
Oversold below −80, overbought above −20
Neutral
CCI (20)
-0.7
Oversold below −100, overbought above 100
Neutral
Rate of change
−2.5%
Change over 10 sessions
Bearish
ATR (14)
$2.94
Typical daily range, 12.5% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Below
MA 200–
What happened before, for ZLAB
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how ZLAB did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow ZLAB usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How ZLAB has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2017.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ZLAB is in one of them and how their past ZLAB trades turned out.
Zai Lab is a biopharmaceutical company based in Shanghai that develops and sells prescription medicines. Its approved products treat conditions including ovarian cancer, generalized myasthenia gravis, glioblastoma, pneumonia and gastrointestinal stromal tumors. The products are sold across Greater China, where the company works with major medical centers and distributors. It also has a presence in the United States and a pipeline of additional candidates.